Study title:
Surgery. 1985 Dec;98(6):1189-96.
Localization of residual medullary thyroid cancer by thallium/technetium
scintigraphy.
Talpos GB, Jackson CE, Froelich JW, Kambouris AA, Block MA, Tashjian AH Jr
Surgery. 1985 Dec;98(6):1189-96.
Localization of residual medullary thyroid cancer by thallium/technetium
scintigraphy.
Talpos GB, Jackson CE, Froelich JW, Kambouris AA, Block MA, Tashjian AH Jr
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Diagnosis [E01]
|
Brands: |
MAH holders: Please see report |
Assessment: |
Active substance: THALLIUM 201T1 CHLORIDE |
ATC code: V09GX01 |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|